• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchEquillium
    Picture of Equillium logo

    EQ — Equillium News Story

    $1.230.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    • Market Cap
      $77.99m
    • Enterprise Value
      $20.83m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • EQ Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    EQ Dividends
    All News

    NASDAQ RESUMED AT 09:55 AM

    Picture of Equillium logoEquillium
    15/02/2022 14:55
    NASDAQ RESUMED  EQ.O  AT 09:55 AM
    

    Recent news on Equillium

    See all news
    • Brief: Equillium Receives Australian Regulatory Clearance To Initiate First-In-Human Clinical Trial Of Eq504

      05/10/2026 22:43
    • Equillium Inc reports results for the quarter ended June 30 - Earnings Summary

      13/08/2026 22:02
    • Equillium Q2 post narrower net loss than expected; starts R&D initiatives

      13/08/2026 21:20
    • Equillium Inc expected to post a loss of 5 cents a share - Earnings Preview

      10/08/2026 22:18
    • Equillium Q1 net loss, profit miss analyst expectations

      13/05/2026 21:08

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.